8-K - P3 Health Partners Inc. (0001832511) (Filer)

8-K - Foresight Acquisition Corp. (0001832511) (Filer)

25-NSE - Foresight Acquisition Corp. (0001832511) (Subject)

DEFA14A - Foresight Acquisition Corp. (0001832511) (Filer)

8-K - Foresight Acquisition Corp. (0001832511) (Filer)

DEFA14A - Foresight Acquisition Corp. (0001832511) (Filer)

DEFA14A - Foresight Acquisition Corp. (0001832511) (Filer)

10-Q/A - Foresight Acquisition Corp. (0001832511) (Filer)

DEFA14A - Foresight Acquisition Corp. (0001832511) (Filer)

DEFA14A - Foresight Acquisition Corp. (0001832511) (Filer)

NEW YORK, Dec. 03, 2021 (GLOBE NEWSWIRE) -- P3 Health Partners ("P3" or "Company"), a patient-centered and physician-led population health management company, announced today that it has closed its previously announced business combination with Foresight Acquisition Corp. (NASDAQ:FORE) ("Foresight"). The transaction was approved at a special meeting of Foresight's stockholders on December 3, 2021. The combined company will be named P3 Health Partners Inc. and will be led by P3's management team. Its shares of Class A common stock and warrants are expected to begin trading December 6, 2021, on the Nasdaq under the ticker symbols "PIII" and "PIIIW", respectively. "At P3, we utilize our pro

NEW YORK, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Foresight Acquisition Corp. (NASDAQ:FORE) ("Foresight") announced that its Special Meeting of Foresight's stockholders (the "Special Meeting") relating to the proposed business combination (the "Business Combination") with P3 Health Partners ("P3") that was initially convened at 9:00 a.m. Central Time on November 18, 2021 and adjourned to today, was reconvened today at 7:00 a.m. Central Time and further adjourned until 7:00 a.m. Central Time on December 3, 2021. As anticipated, the Special Meeting was further adjourned to provide Foresight and P3 additional time to file a proxy supplement to the definitive proxy statement that was filed with the

NEW YORK, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Foresight Acquisition Corp. (NASDAQ:FORE) ("Foresight") announced that its Special Meeting of Foresight's stockholders (the "Special Meeting") relating to the proposed business combination (the "Business Combination") with P3 Health Partners ("P3") was convened today at 9:00 a.m. Central Time and adjourned until 7:00 a.m. Central Time on November 24, 2021. The Special Meeting was adjourned to give Foresight's stockholders additional time to consider additional disclosure to be included in a supplement to the Proxy Statement that was filed with the Securities and Exchange Commission ("SEC") on October 28, 2021 (the "Proxy Statement") and mailed to

NEW YORK, Nov. 11, 2021 (GLOBE NEWSWIRE) -- P3 Health Partners ("P3" or the "Company"), a patient-centered and physician-led population health management company, today announced the Company's expansion into California's Central Valley through its acquisition of Medcore HP ("MHP"), a health plan licensed under the California Knox-Keene Health Care Service Plan Act of 1975, and Omni IPA Medical Group, Inc. ("Omni"), an independent practice association in San Joaquin County, California. P3 brings its proven talent, tools and technology to help providers deliver high-quality, cost-effective care to patients in the Central Valley. The transaction is expected to close by the end of the year bu

NEW YORK, Nov. 05, 2021 (GLOBE NEWSWIRE) -- P3 Health Partners ("P3"), a patient-centered and physician-led population health management company, which announced earlier this year that it expects to become a public company via a merger with special purpose acquisition company, Foresight Acquisition Corp. (NASDAQ:FORE) ("Foresight"), is scheduled to participate at the following virtual events in November 2021: Credit Suisse Healthcare ConferencePresentation: Monday, November 8th at 1:00pm Eastern timeWebcast: Link P3 Virtual Investor DayPresentation: Thursday, November 11th at 1:00pm Eastern timeWebcast: Link BTIG Digital Health Forum Presentation: Monday, November 15th at 10:00am Easter

NEW YORK, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Foresight Acquisition Corp. (NASDAQ:FORE) ("Foresight") and P3 Health Partners ("P3"), a patient centered and physician led population health management company, announced that on October 28, 2021, Foresight filed a definitive proxy statement (the "Proxy Statement") relating to the proposed business combination (the "Business Combination") with P3. Foresight also announced that a special meeting of its stockholders will be held at 9:00 a.m. Central Time on November 18, 2021, in connection with the Business Combination (the "Special Meeting"). The Proxy Statement is being mailed to Foresight's stockholders of record as of the close of business on 

NEW YORK, NY / ACCESSWIRE / September 2, 2021 / P3 Health Partners ("P3"), a patient-centered and physician-led population health management company, which recently announced its business combination with Foresight Acquisition Corp. (NASDAQ:FORE), a publicly traded special purpose acquisition company, is scheduled to participate at the following virtual financial conferences in September 2021:10th Annual Gateway ConferencePresentation: Thursday, September 9th at 11:30am Eastern timeWebcast: LinkWells Fargo Virtual Healthcare ConferencePresentation: Friday, September 10th at 11:20am Eastern timeWebcast: LinkTo receive additional information, request an invitation or to schedule a one-on-one m

Executives from a Range of Industries to Present to 500+ Investors and AnalystsNEWPORT BEACH, CA / ACCESSWIRE / August 24, 2021 / The Gateway Conference is back for its 10th year and will showcase leading public and private companies virtually on September 8th and 9th.Attendees will have the opportunity to discover and learn about a select group of compelling companies across a wide range of industries, including consumer & wellness, financials, internet & business services, industrials, technology & electric vehicles, and SPACs.The invitation-only conference provides investors and analysts a unique opportunity to gain valuable insights during two days of presentations and one-on-one meeting

- Transaction to Publicly List P3 Health Partners, a Patient-Centered and Physician-Led Population Health Management Company Delivering Value-Based Care - - Estimated Post-Transaction Enterprise Value of $2.3 Billion With Over $180 Million in Cash to Fund Growth - - Transaction Includes an Over $200 Million Fully Committed Common Stock Private Investment at $10 Per Share Including Participation From Funds and Accounts Managed by Fidelity Management & Research Company LLC and Janus Henderson Investors - NEW YORK, May 25, 2021 (GLOBE NEWSWIRE) --  P3 Health Partners ("P3") and Foresight Acquisition Corp. (NASDAQ:FORE) ("Foresight") have entered into a definitive agreement which would resu